SCHEDULE: Versa Capital Exits Picard Medical Position

Versa Capital Management and associated entities have reported a zero percent beneficial ownership stake in Picard Medical, Inc.

Summary

• The filing serves as an Amendment No. 1 to a Schedule 13G.
• Reporting persons, including Sindex SSI Lending, LLC, Versa Capital Fund III, L.P., and Gregory L. Segall, report 0% beneficial ownership of Picard Medical, Inc. common stock.
• The event triggering this filing occurred on June 3, 2025.
• The reporting persons certify that they no longer hold shares for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; it is a standard regulatory disclosure confirming the cessation of a reporting obligation due to zero ownership.

Positives

• The filing provides transparency regarding the complete divestment of the reporting entities from the issuer.

Negatives

• The exit of a significant institutional investor group may signal a lack of long-term confidence or a strategic shift in their portfolio management.

Risks

• Potential market volatility resulting from the perception of institutional divestment.
• Reduced liquidity if the reporting persons were significant holders prior to this exit.

Future Outlook

No future outlook or guidance is provided as the reporting persons have fully divested their interest in the company.

Industry Context

StockSavvy.ai notes that institutional exits from small-cap medical technology firms often reflect portfolio rebalancing or the conclusion of a specific investment thesis rather than a fundamental change in the issuer's business model.

Comparison to Industry Standards

• The filing follows standard regulatory requirements for reporting changes in beneficial ownership under the Securities Exchange Act of 1934.

Stakeholder Impact

• Shareholders may view the complete exit of Versa Capital as a signal to re-evaluate their own positions in the company.

Next Steps

• No further reporting obligations for these entities regarding Picard Medical, Inc. unless ownership thresholds are crossed again.

Key Dates

Keywords

Picard Medical, Versa Capital, Schedule 13G, Divestment, Beneficial Ownership, SEC Filing